Mandate

Vinge advises Geveko in connection with its new share issue

February 25, 2010

AB Geveko (publ) has resolved to carry out a new share issue with preferential rights for the shareholders. Through the new issue, which is fully committed and underwritten, the company will raise approximately SEK 160 million excluding transaction costs. The new issue is subject to approval by the extraordinary shareholders’ meeting on 31 March 2010.

AB Geveko is listed on NASDAQ OMX Stockholm.

Vinge’s team consisted primarily of responsible partner Göran Nyström and the associates Anna Björk Larson and Emil Hedberg.

Related

Vinge advises Isofol Medical AB (publ) in connection with its rights issue of units

Through the rights issue of units, consisting of shares and warrants, and the exercised over-allotment issue, Isofol will receive approximately SEK 84 million and may receive an additional maximum of approximately SEK 110 million upon exercise of all warrants at the highest subscription price.
August 01, 2025

Vinge advises Oncorena in connection with share issue

Vinge advises Oncorena Holding AB in connection with a share issue of approximately SEK 133 million.
July 30, 2025

Vinge advises Karl Hedin and minority owners on the sale of AB Karl Hedin Sågverk to Vida

Vinge has advised Karl Hedin and minority shareholders in connection with the sale of AB Karl Hedin Sågverk to Vida Aktiebolag (“Vida”).
July 24, 2025